Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Turk Neurosurg ; 21(1): 48-52, 2011 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-21294091

RESUMO

AIM: To assess the long-term outcomes of percutaneous retrogasserian glycerol rhizotomy (PRGR) in patients with medically unresponsive idiopathic trigeminal neuralgia. MATERIAL AND METHODS: A total of 3370 patients undergoing PRGR between 1983 and 2003 in our hospital were followed up for 13.1 years (range 3-23 years), and the outcomes were investigated. RESULTS: Of the 3370 patients, 99.58% had complete initial pain relief. A total of 2750 patients were followed up when 112 died of unrelated causes and 508 were lost to follow up. Of the 2750 patients, 962 (35%) had pain recurrence at various intervals: 0.3% in 1 year; 21% in 1 to 5 years; 7% in 5 to 10 years; 4% in 10 to 15 years and 3% in 15 to 23 years. The major complication was facial numbness, among which hypesthesia outweighed hypalgesia. Most patients recovered within half a year, although 109 patients (3.96%) developed permanent mild hypesthesia. There was no anesthesia dolorosa or surgery related mortality in this series. CONCLUSION: PRGR is a minimally invasive and simple procedure yielding a favorable outcome for trigeminal neuralgia. The major complications of this procedure are reversible within various time intervals. It may serve as a first-line surgical modality for patients unresponsive to pharmacotherapy.


Assuntos
Glicerol/uso terapêutico , Procedimentos Cirúrgicos Minimamente Invasivos/métodos , Rizotomia/métodos , Neuralgia do Trigêmeo/cirurgia , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Complicações Pós-Operatórias , Postura , Recidiva , Resultado do Tratamento
2.
Artigo em Inglês | WPRIM (Pacífico Ocidental) | ID: wpr-272955

RESUMO

<p><b>OBJECTIVE</b>To retrospectively analyze 95 cases of traumatic carotid cavernous fistula treated by endovascular embolization.</p><p><b>METHODS</b>From January 1994 to December 2008, 95 patients with traumatic carotid cavernous fistula were treated in our hospital. All patients received selective cerebral angiography through femoral artery catheterization. Accordingly, 89 cases were treated by detachable balloon embolization, 5 by platinum microcoils and 1 by covered-stent, respectively.</p><p><b>RESULTS</b>In the study, 61 cases achieved successful balloon embolization at the first time. Fifty-six cases had multiple balloons due to the big fistula. Nine cases received balloon embolization twice. But among the 5 patients treated with platinum microcoils, one developed slight brainstem ischemia. After operation the patient had hemiparesis and swallow difficulty, but gradually recovered 3 months later. No neurological deficits were observed in other cases. All the cases recovered. Eighty-five cases were followed up for 1-15 years and no recurrence was found.</p><p><b>CONCLUSIONS</b>The endovascular embolization for traumatic carotid cavernous fistula is minimally invasive, safe, effective and reliable. The detachable balloon embolization is the first choice in the treatment of TCCF.</p>


Assuntos
Adolescente , Adulto , Idoso , Criança , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Oclusão com Balão , Métodos , Fístula Carótido-Cavernosa , Diagnóstico , Terapêutica , Embolização Terapêutica , Métodos , Emergências , Estudos Retrospectivos , Stents
3.
Artigo em Chinês | WPRIM (Pacífico Ocidental) | ID: wpr-270421

RESUMO

<p><b>OBJECTIVE</b>To assess bone health in epileptic children who have been treated with topiramate (TPM) or carbamazepine (CBZ).</p><p><b>METHODS</b>Sixty-three epileptic children who received TPM or CBZ treatment and 36 eileptic children who did not receive any drug treatment (control group) were enrolled. Bone mineral density (BMD) at lumbar vertebrae (L1-L4) and radius-ulna was evaluated by the dual-energy X-ray absorptiometry method. Biochemical indices of bone metabolism, including serum calcium, phosphorus and alkaline phosphatase contents were measured.</p><p><b>RESULTS</b>The serum calcium content was higher in the TPM group (2.41+/-0.17 mmol/L), but it was lower in the CBZ group (2.15+/-0.26 mmol/L) than that (2.26+/-0.11 mmol/L) in the control group (p<0.05). The serum phosphorus content in both the TPM (1.55+/-0.17 mmol/L) and the CBZ groups (1.52+/-0.26 mmol/L) was significantly lower than that in the control group (1.70+/-0.30 mmol/L) (p<0.05). There were no significant differences in the serum content of alkaline phosphatase between three groups. BMD was significantly reduced in both the TPM and the CBZ groups when compared to the control group (p<0.05).</p><p><b>CONCLUSIONS</b>TPM and CBZ may result in alterations in serum contents of calcium, phosphorus and alkaline phosphatase as well as BMD reduction.</p>


Assuntos
Adolescente , Criança , Pré-Escolar , Feminino , Humanos , Masculino , Fosfatase Alcalina , Sangue , Anticonvulsivantes , Densidade Óssea , Osso e Ossos , Metabolismo , Cálcio , Sangue , Carbamazepina , Epilepsia , Tratamento Farmacológico , Metabolismo , Frutose , Fósforo , Sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...